DeNova Research

DeNova Research is a premier clinical research site based in Chicago, specializing in aesthetic and medical dermatology. The company conducts Phase II through IV clinical trials for leading pharmaceutical and medical device companies, focusing on innovative treatments for skin conditions and aesthetic enhancements. Their expertise encompasses a wide range of products, including neurotoxins, dermal fillers, laser devices, and topical therapeutics. By bridging the gap between laboratory research and clinical practice, DeNova Research plays a critical role in the development and validation of new dermatological technologies. The site is recognized for its high patient recruitment rates and rigorous adherence to clinical protocols. Led by Dr. Steven Dayan, the organization is a key contributor to the clinical evidence base for many FDA-approved aesthetic treatments.